NanoEcho completed a key clinical milestone and strengthened its financial position through a rights issue, while advancing its AI-driven diagnostic system for rectal cancer. The company published a health economic analysis supporting its method's cost-effectiveness.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.